Faik Uzunoglu
Priv.-Doz. Dr. med.
Faik G. Uzunoglu
  • Functional senior physician
  • Medical Specialist in Visceral Surgery
  • Special Visceral Surgery
Working area

Location

Main Building O10 , 2nd Floor
Languages
German (Mother tongue)
English
Turkish

Areas of expertise

Publications

Zurück
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
Vor

Decentralized colorectal cancer care in Germany over the last decade is associated with high in-hospital morbidity and mortality
Ghadban T, Reeh M, Bockhorn M, Grotelueschen R, Bachmann K, Grupp K, Uzunoglu F, Izbicki J, Perez D
CANCER MANAG RES. 2019;11:2101-2107.

Prospective Comparison of the Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of a Single Patient's Cohort With Esophageal Cancer
Konczalla L, Ghadban T, Effenberger K, Wöstemeier A, Riethdorf S, Uzunoglu F, Izbicki J, Pantel K, Bockhorn M, Reeh M
ANN SURG. 2019.

Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer
Konczalla L, Perez D, Wenzel N, Wolters-Eisfeld G, Klemp C, Lüddeke J, Wolski A, Landschulze D, Meier C, Buchholz A, Yao D, Hofmann B, Graß J, Spriestersbach S, Grupp K, Schumacher U, Betzel C, Kapis S, Nuguid T, Steinberg P, Püschel K, Sauter G, Bockhorn M, Uzunoglu F, Izbicki J, Güngör C, El Gammal A
INT J CANCER. 2019 [Epub ahead of print].

Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome
Grupp K, Hofmann B, Kutup A, Bachmann K, Bogoevski D, Melling N, Uzunoglu F, El Gammal A, Koop C, Simon R, Steurer S, Krech T, Burdak-Rothkamm S, Jacobsen F, Sauter G, Izbicki J, Wilczak W
BMC CANCER. 2018;18(1):1106.

FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas
Grupp K, Uzunoglu F, Melling N, Hofmann B, El Gammal A, Grotelüschen R, Heumann A, Bellon E, Reeh M, Wolters-Eisfeld G, Ghabdan T, Nentwich M, Bachmann K, Bockhorn M, Bogoevski D, Izbicki J, Kutup A
SCI REP-UK. 2018;8(1):17370.

Absence of HER2 Expression of Circulating Tumor Cells in Patients with Non-Metastatic Esophageal Cancer
Woestemeier A, Ghadban T, Riethdorf S, Harms-Effenberger K, Konczalla L, Uzunoglu F, Izbicki J, Pantel K, Bockhorn M, Reeh M
ANTICANCER RES. 2018;38(10):5665-5669.

Duodenumerhaltende Pankreaskopfresektion
Meiners J, Perez D, Izbicki J, Uzunoglu F
2017. Expertise Pankreas. Izbicki J, Perez D (eds.). 1. ed. Georg Thieme Verlag KG, 98-102.

Blood fibrinogen levels discriminate low- and high-risk intraductal papillary mucinous neoplasms (IPMNs)
Nentwich M, Menzel K, Reeh M, Uzunoglu F, Ghadban T, Bachmann K, Schrader J, Bockhorn M, Izbicki J, Perez D
EJSO-EUR J SURG ONC. 2017;43(4):758-762.

Allogenic Blood Transfusion is Associated with Poor Perioperative and Long-Term Outcome in Esophageal Cancer
Reeh M, Ghadban T, Dedow J, Vettorazzi E, Uzunoglu F, Nentwich M, Kluge S, Izbicki J, Vashist Y
WORLD J SURG. 2017;41(1):208-215.

Hamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma
Reeh M, Ghadban T, Uzunoglu F, Nentwich M, Bockhorn M, Pantel K, Izbicki J, Vashist Y
BRIT J CANCER. 2017;117(5):612-618.

Diverse prognostic value of the GTn promoter polymorphism in squamous cell and adeno carcinoma of the esophageus
Ghadban T, Miro J, Trump F, Tsui T, Uzunoglu F, Reeh M, Gebauer F, Bachmann K, Wellner U, Kalinin V, Pantel K, Izbicki J, Vashist Y
CLIN GENET. 2016;90(4):343-50.

Characterization of different CTC subpopulations in non-small cell lung cancer
Hanssen A, Wagner J, Gorges T, Tänzer A, Uzunoglu F, Driemel C, Stoecklein N, Knoefel W, Angenendt S, Hauch S, Atanackovic D, Loges S, Riethdorf S, Pantel K, Wikman H
SCI REP-UK. 2016;6:28010.

Glasgow Prognostic Score may be a prognostic index for overall and perioperative survival in gastric cancer without perioperative treatment
Melling N, Grüning A, Tachezy M, Nentwich M, Reeh M, Uzunoglu F, Vashist Y, Izbicki J, Bogoevski D
SURGERY. 2016;159(6):1548-56.

Non-trauma Emergency Pancreatoduodenectomies: A Single-Center Retrospective Analysis
Nentwich M, Reeh M, Uzunoglu F, Bachmann K, Bockhorn M, Izbicki J, Vashist Y
WORLD J SURG. 2016;40(9):2261-6.

The PER (Preoperative Esophagectomy Risk) Score: A Simple Risk Score to Predict Short-Term and Long-Term Outcome in Patients with Surgically Treated Esophageal Cancer
Reeh M, Metze J, Uzunoglu F, Nentwich M, Ghadban T, Wellner U, Bockhorn M, Kluge S, Izbicki J, Vashist Y
MEDICINE. 2016;95(7):e2724.

The Author Reply
Reeh M, Uzunoglu F
HEPATOB PANCREAT DIS. 2016;15(1):109-10.

Evaluation of the germline single nucleotide polymorphism rs583522 in the TNFAIP3 gene as a prognostic marker in esophageal cancer
Ghadban T, Schmidt-Yang M, Uzunoglu F, Perez D, El Gammal A, Miro J, Wellner U, Pantel K, Izbicki J, Vashist Y
CANCER GENET-NY. 2015;208(12):595–601.

Correction to: An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer
Ghadban T, Schmidt-Yang M, Uzunoglu F, Perez D, Tsui T, El Gammal A, Erbes P, Zilbermints V, Wellner U, Pantel K, Izbicki J, Vashist Y
J HUM GENET . 2015;60(2):107.

Salvage Completion Pancreatectomies as Damage Control for Post-pancreatic Surgery Complications: A Single-Center Retrospective Analysis
Nentwich M, El Gammal A, Lemcke T, Ghadban T, Bellon E, Melling N, Bachmann K, Reeh M, Uzunoglu F, Izbicki J, Bockhorn M
WORLD J SURG. 2015;39(6):1550-6.

Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer
Reeh M, Harms-Effenberger K, Koenig A, Riethdorf S, Eichstädt D, Vettorazzi E, Uzunoglu F, Vashist Y, Izbicki J, Pantel K, Bockhorn M
ANN SURG. 2015;261(6):1124-30.

Locally advanced esophageal carcinoma: is there still a role of surgery alone without neoadjuvant treatment?
Reeh M, Nentwich M, Asani S, Uzunoglu F, Bockhorn M, Sauter G, Rösch T, Izbicki J, Bogoevski D
J GASTROINTEST SURG. 2015;19(4):587-93.

Identification of HERC5 and its potential role in NSCLC progression
Wrage M, Hagmann W, Kemming D, Uzunoglu F, Riethdorf S, Harms-Effenberger K, Westphal M, Lamszus K, Kim S, Becker N, Izbicki J, Sandoval J, Esteller M, Pantel K, Risch A, Wikman-Kocher H
INT J CANCER. 2015;136(10):2264-72.

Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
Bockhorn M, Uzunoglu F, Adham M, Imrie C, Milicevic M, Sandberg A, Asbun H, Bassi C, Büchler M, Charnley R, Conlon K, Cruz L, Dervenis C, Fingerhutt A, Friess H, Gouma D, Hartwig W, Lillemoe K, Montorsi M, Neoptolemos J, Shrikhande S, Takaori K, Traverso W, Vashist Y, Vollmer C, Yeo C, Izbicki J
SURGERY. 2014;155(6):977-988.

An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer
Ghadban T, Schmidt-Yang M, Uzunoglu F, Perez D, Tsui T, El Gammal A, Erbes P, Zilbermints V, Wellner U, Pantel K, Izbicki J, Vashist Y
J HUM GENET . 2014;59(12):661-666.

Multimodale Therapie des Ösophaguskarzinoms: Pro und Kontra
Hölscher A, Fetzner U, Uzunoglu F, Izbicki J
Allgemein- und Viszeralchirurgie up2date. 2014;8(3):199-214.

Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus
Nentwich M, Loga K, Reeh M, Uzunoglu F, Marx A, Izbicki J, Bogoevski D
J GASTROINTEST SURG. 2014;18(2):242-9.

The multifunctional growth factor midkine promotes proliferation and migration in pancreatic cancer
Rawnaq T, Dietrich L, Wolters-Eisfeld G, Uzunoglu F, Vashist Y, Bachmann K, Simon R, Izbicki J, Bockhorn M, Güngör C
MOL CANCER RES. 2014;12(5):670-80.

Loss of 4q21.23-22.1 is a Prognostic Marker for Disease Free and Overall Survival in Non-Small Cell Lung Cancer
Uzunoglu F, Dethlefsen E, Hanssen A, Wrage M, Deutsch L, Harms-Effenberger K, Vashist Y, Reeh M, Sauter G, Simon R, Bockhorn M, Pantel K, Izbicki J, Wikman-Kocher H
PLOS ONE. 2014;9(12):e113315.

The potential for targeting HER2 therapeutically in esophageal cancer - a grasp at straws?
Uzunoglu F, Koenig A, Izbicki J
EXPERT OPIN THER TAR. 2014;18(12):1421-6.

Preoperative Pancreatic Resection (PREPARE) score: a prospective multicenter-based morbidity risk score
Uzunoglu F, Reeh M, Vettorazzi E, Ruschke T, Hannah P, Nentwich M, Vashist Y, Bogoevski D, König A, Janot M, Gavazzi F, Zerbi A, Todaro V, Malleo G, Uhl W, Montorsi M, Bassi C, Izbicki J, Bockhorn M
ANN SURG. 2014;260(5):857-64.

Single versus double Roux-en-Y reconstruction techniques in pancreaticoduodenectomy: a comparative single-center study
Uzunoglu F, Reeh M, Wollstein R, Melling N, Perez D, Vashist Y, Bogoevski D, Izbicki J, Bockhorn M
WORLD J SURG. 2014;38(12):3228-3234.

Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma
König A, Reeh M, Dancau A, Rathjens M, Gros S, Uzunoglu F, Bockhorn M, Simon R, Sauter G, Marx A, Izbicki J
ANTICANCER RES. 2013;33(11):4975-82.

Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer
Nentwich M, Bohn B, Uzunoglu F, Reeh M, Quaas A, Grob T, Perez D, Kutup A, Bockhorn M, Izbicki J, Vashist Y
J THORAC CARDIOV SUR. 2013;146(4):781-7.

LigaSure™ vs. conventional dissection techniques in pancreatic surgery--a prospective randomised single-centre trial.
Uzunoglu F, Bockhorn M, Fink J, Reeh M, Vettorazzi E, Gawad K, Bogoevski D, Vashist Y, Tsui T, Koenig A, Mann O, Izbicki J
J GASTROINTEST SURG. 2013;17(3):494-500.

The T393C polymorphism of GNAS1 is a predictor for relapse and survival in resectable non-small cell lung cancer.
Uzunoglu F, Heumann A, Musici S, Kutup A, König A, Roch N, Thomssen A, Dohrmann T, Tsui T, Mann O, Izbicki J, Vashist Y
LUNG CANCER. 2013;79(2):151-155.

VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma
Uzunoglu F, Kolbe J, Wikman H, Güngör C, Bohn B, Nentwich M, Reeh M, König A, Bockhorn M, Kutup A, Mann O, Izbicki J, Vashist Y
ANN ONCOL. 2013;24(5):1282-90.

Surgery of esophageal cancer
Uzunoglu F, Reeh M, Kutup A, Izbicki J
LANGENBECK ARCH SURG. 2013;398(2):189-93.

C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLC
Uzunoglu F, Yavari N, Bohn B, Nentwich M, Reeh M, Pantel K, Perez D, Tsui T, Bockhorn M, Mann O, Izbicki J, Wikman H, Vashist Y
LUNG CANCER. 2013;81(1):123-9.

Opposite roles of FOXA1 and NKX2-1 in lung cancer progression.
Deutsch L, Wrage M, Koops S, Glatzel M, Uzunoglu F, Kutup A, Hinsch A, Sauter G, Izbicki J, Pantel K, Wikman H
GENE CHROMOSOME CANC. 2012;51(6):618-629.

An attempt at validation of the Seventh edition of the classification by the International Union Against Cancer for esophageal carcinoma.
Reeh M, Nentwich M, von Loga K, Schade J, Uzunoglu F, König A, Bockhorn M, Rösch T, Izbicki J, Bogoevski D
ANN THORAC SURG. 2012;93(3):890-896.

Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
Uzunoglu F, Kaufmann C, Wikman H, Güngör C, Bohn B, Nentwich M, Reeh M, Pantel K, Bockhorn M, Kutup A, Mann O, Izbicki J, Vashist Y
ANN SURG ONCOL. 2012;19(7):2159-2168.

Notfallsternotomie bei perkutaner zentralvenöser Punktion - ein Fallbericht
Uzunoglu F, Koenig A, Bockhorn M, Cataldegirmen G, Izbicki J, Benhidjeb T
ZBL CHIR. 2012;137(3):262-3.

[Emergency sternotomy during percutaneous central venous catheterisation - a case report].
Uzunoglu F, König A, Bockhorn M, Cataldegirmen G, Izbicki J, Benhidjeb T
ZBL CHIR. 2012;137(3):262-263.

Ultrasonic dissection versus conventional dissection techniques in pancreatic surgery: a randomized multicentre study
Uzunoglu F, Stehr A, Fink J, Vettorazzi E, Koenig A, Gawad K, Vashist Y, Kutup A, Mann O, Gavazzi F, Zerbi A, Bassi C, Dervenis C, Montorsi M, Bockhorn M, Izbicki J
ANN SURG. 2012;256(5):675-9; discussion 679-80.

Ultrasonic dissection versus conventional dissection techniques in pancreatic surgery: a randomized multicentre study.
Uzunoglu F, Stehr A, Fink J, Vettorazzi E, König A, Gawad K, Vashist Y, Kutup A, Mann O, Gavazzi F, Zerbi A, Bassi C, Dervenis C, Montorsi M, Bockhorn M, Izbicki J
ANN SURG. 2012;256(5):675-680.

The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer.
Vashist Y, Kutup A, Musici S, Yekebas E, Mina S, Uzunoglu F, Zehler O, König A, Cataldegirmen G, Bockhorn M, Harms-Effenberger K, Kalinin V, Pantel K, Izbicki J
CELL ONCOL. 2011;34(4):281-288.

Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer.
Vashist Y, Loos J, Dedow J, Tachezy M, Uzunoglu F, Kutup A, Yekebas E, Izbicki J
ANN SURG ONCOL. 2011;18(4):1130-1138.

Heme oxygenase-1 promoter polymorphism is a predictor of disease relapse in pancreatic neuroendocrine tumors.
Vashist Y, Uzunoglu F, Deutsch L, Kalinin V, Zehler O, Alzadjali A, Kutup A, Izbicki J, Yekebas E
J SURG RES. 2011;166(2):121-127.

Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer.
Vashist Y, Uzunoglu F, Kutup A, Gebauer F, König A, Deutsch L, Zehler O, Busch P, Kalinin V, Izbicki J, Yekebas E
J SURG ONCOL. 2011;104(3):305-311.

Letzte Aktualisierung aus dem FIS: 14.10.2019 - 05:26 Uhr